Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approach.
about
Drug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening MethodologiesMolecular docking and structure-based drug design strategiesComputational methods in drug discoveryDrugE-Rank: improving drug-target interaction prediction of new candidate drugs or targets by ensemble learning to rankApplications of computer-aided approaches in the development of hepatitis C antiviral agents.Computational methods in drug discovery.Structural insights into mode of actions of novel natural Mycobacterium protein tyrosine phosphatase B inhibitors.Antimicrobial activity and cytotoxicity of some 2-amino-5-alkylidene-thiazol-4-ones.Current progress in Structure-Based Rational Drug Design marks a new mindset in drug discoveryFocused chemical libraries--design and enrichment: an example of protein-protein interaction chemical space.Combinatorial Pharmacophore-Based 3D-QSAR Analysis and Virtual Screening of FGFR1 Inhibitors.Effect of the Crystal Environment on Side-Chain Conformational Dynamics in Cyanovirin-N Investigated through Crystal and Solution Molecular Dynamics Simulations.Structure and ligand based drug design strategies in the development of novel 5- LOX inhibitors.Computational drug discovery.Size does matter! Label-free detection of small molecule-protein interaction.Quantitative structure-activity relationship: promising advances in drug discovery platforms.In silico frameworks for systematic pre-clinical screening of potential anti-leukemia therapeutics.An iterative compound screening contest method for identifying target protein inhibitors using the tyrosine-protein kinase Yes.Pharmacological use of a novel scaffold, anomeric N,N-diarylamino tetrahydropyran: molecular similarity search, chemocentric target profiling, and experimental evidence.AFAL: a web service for profiling amino acids surrounding ligands in proteins.Intrinsic energy landscapes of amino acid side-chains.Computer-Aided Drug Design Applied to Marine Drug Discovery: Meridianins as Alzheimer's Disease Therapeutic Agents.Prediction of Anti-Alzheimer's Activity of Flavonoids Targeting Acetylcholinesterase in silico.Computer aided drug design and its application to the development of potential drugs for neurodegenerative disorders.Computer-Aided Drug Design Methods.Kororamides, Convolutamines, and Indole Derivatives as Possible Tau and Dual-Specificity Kinase Inhibitors for Alzheimer's Disease: A Computational Study
P2860
Q26745421-9ACA9D04-0C0B-448D-BD1C-728B64E69A32Q26800097-A4FB0143-BAF1-4AD2-95B6-AAC9248A26CFQ26997089-E9A7BEAE-177F-4773-9CB4-7D946E3CB2FAQ28830286-1419BD43-688C-4314-ADEF-91A4B31C0D76Q30238530-669C12E8-6438-4A69-BC2B-98F1830367D0Q30398071-D98F95AE-10A8-41BA-97E0-672F87B20D24Q33715761-2DECD36D-2BEB-4E29-B7EF-5F1E47F33DF7Q34996004-DECB2311-A85A-4FE7-9AB4-4D939B667C4DQ35136572-17A46C28-118D-4E35-8B46-3D833D429F7CQ35158672-6B59B711-6986-4B75-9E0E-EF009E58A579Q35814029-DE7635AE-523B-4143-ABCF-96C6843A63E0Q36255912-B237EFCA-A19C-4301-9E70-74370D61D983Q36345885-73D01DAA-7B03-4802-B205-63280E5C9BE0Q37729463-AED78EB8-81F6-4D8F-B4BD-F110E2D39515Q38210964-7C6F0805-E8DC-4D35-8B7D-33F7C42E2753Q38584487-454979B5-6E99-48AE-9F06-61F4363DB05FQ38968891-A954D4C5-1FD2-4B58-8283-F3579243867DQ41696939-966A779C-5F7C-408C-A87B-CF5FDAAD8EEFQ41998941-9B8E16FB-9543-4877-93FC-EA741918E49DQ42131971-D3156D89-8FA6-4EA6-BB63-D5A8AEFD6B9EQ42240015-0906615A-9F90-4F11-9143-138D6FE273E3Q46251798-207A8F27-1F2E-428E-8E27-D655C9F779AAQ46422016-D8F6C3E6-302E-4D91-AB27-891539799D25Q47889903-9D4E77DD-4FAA-43DC-9792-A6D38355E468Q51311450-7639E93D-5AED-4A1B-A115-A0BA04C0F89CQ58557345-A06ABE74-B0CC-4BC0-B1DE-1886E3EB9468
P2860
Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approach.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Recent advances in ligand-base ...... ampled pharmacophore approach.
@ast
Recent advances in ligand-base ...... ampled pharmacophore approach.
@en
Recent advances in ligand-base ...... ampled pharmacophore approach.
@nl
type
label
Recent advances in ligand-base ...... ampled pharmacophore approach.
@ast
Recent advances in ligand-base ...... ampled pharmacophore approach.
@en
Recent advances in ligand-base ...... ampled pharmacophore approach.
@nl
prefLabel
Recent advances in ligand-base ...... ampled pharmacophore approach.
@ast
Recent advances in ligand-base ...... ampled pharmacophore approach.
@en
Recent advances in ligand-base ...... ampled pharmacophore approach.
@nl
P2093
P2860
P1476
Recent advances in ligand-base ...... sampled pharmacophore approach
@en
P2093
Andrew Coop
Chayan Acharya
James E Polli
P2860
P356
10.2174/157340911793743547
P577
2011-03-01T00:00:00Z